L.B. Nagar,
Hyderabad
Lakdi-Ka-Pul,
Hyderabad
Parel,
Mumbai
Kengeri,
Bengaluru
Perumbakkam – Sholinganallur,
Chennai
L.B. Nagar,
Hyderabad Lakdi-Ka-Pul,
Hyderabad Parel,
Mumbai Kengeri,
Bengaluru Perumbakkam – Sholinganallur,
Chennai
Liver Nutritionist in the Department of Hepatology at Gleneagles Hospital, Mumbai.
Proficient in assessing and counselling on tailored nutrition plans for individuals with liver disease, sarcopenia and metabolic syndrome. A post-doctoral fellow at IIT Bombay, Department of Bioscience and Bioengineering, establishing 3D liver model for metabolic and drug studies.
Research Area: NASH, Sarcopenia
14+ years of experience
Designation: Women Scientist – A (Principal Investigator)
Period: May 2015 to May 2018
Agency: Department of Science and Technology (DST), Government of India
Grant number: SR/WOS-A/LS-1135/2014
Title of project: Investigate metabolic toxicity in hepatic steatosis cell model in the presence and absence of phytoactives.
Poster presentation – 1st prize
Conference name: International Conference on Obesity and Chronic disease.
Location: Las Vegas, USA Year: July 2016
Title of the poster: Simulation of an in vitro NAFLD model showed inhibition of lipid accumulation and lipotoxicity by Picroside II.
Poster presentation – 1st prize
Conference name: Indian Association for study of Liver
Location: Delhi, India Year: August 2018
Title of the poster: Picroside II reduces lipid accumulation, oxidative stress and mitochondrial dysfunction in in vitro NAFLD model.
Young Investigator Award
Conference name: European Association for study of liver
Location: Seville, Spain Year: September 2019
Title: Picroside II reduces FFAs-induced lipid accumulation and lipotoxicity in an in vitro model of NAFLD.
Young Investigator Award
Conference name: Indian National Association for study of liver
Location: Bhubaneshwar, Odisha Year: August 2023
Title: Identification of High-Risk Sarcopenic Phenotypes in End-Stage Liver Disease & their Association with 1-year post-transplant mortality
BSc (Dietetics), MSc (CN), PhD (FSN), PDF (CTE)
2024
Manuscript under preparation
Hiteshi Dhami-Shah, Gautham Pranesh, Disha Mogre, Rashmi Badhe, Ameet Mandot, Parul Garde, Madhuri Nigudkar, Anuradha Ramesh, Jagmeet Madan, Samir Shah. Phenotypic Clustering Identifies High-Risk Profiles for Sarcopenia and 1-Year post-transplant Mortality in Patients with End-Stage Liver Disease
Hiteshi Dhami-Shah, Disha Mogre, Gautham Pranesh, Rashmi Badhe, Tanvi Chipkar, Ameet Mandot, Parul Garde, Madhuri Nigudkar, Anuradha Ramesh, Jagmeet Madan, Samir Shah. Gender-Specific Sarcopenia Parameter Cut-Off Values for Cirrhosis Patients.
2022 Raut A, Dhami-Shah Hiteshi, Phadke A, Shindikar A, Udipi S, Joshi J, Vaidya R, Vaidya ADB. Picrorhiza kurroa, Royle ex Benth:Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. J Ayurveda Integr Med. 2022. Dhami–Shah Hiteshi, Vaidya Ashok. Making excellence a habit: The secret to building a world-class healthcare system in India by V. Mohan. J Ayurveda Integr Med. 2022;13:100514.
2021 Dhami-Shah Hiteshi, Vaidya R, Talwadekar M, Shaw E, Udipi S, Kolthur-Seetharam U, Vaidya ADB. Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells. J Ayurveda Integr Med. 2021;2:S0975-9476(21)00063-2.
2020
Shah Samir, Dhami-Shah Hiteshi, Kamble Swati, Shukla Akash.FIB4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with NAFLD. Journal of Hepatology. 2020; S0168-8278(20)30017-9.
2019
Vaidya Ashok, Dhami Hiteshi, Udipi Shobha. Natural Medicines – categories, comebacks and catalysts. In Ghosh D, Mukherjee P (Eds) Natural Medicines, Clinical efficacy, safety and quality. 1st edition. USA: CRC press; 2019.
Vaidya Rama, Rege Nayna, Desai Sharvari, Dhami Hiteshi, Agashe Shubhada, Talwalkar Sadananda, Udipi Shobha, Vaidya Ashok. Sleep Aberrations in Polycystic Ovarian Syndrome: An Observational Study of 38 Women. Indian Practioner. 2019; 72 (9): 25 – 29.
Kothari Sneha, Dhami–Shah Hiteshi, Shah Samir. Anti-diabetic drugs and statins in NAFLD. Journal of Clinical and Experimental Hepatology. 2019; 9(6):723 – 730.
2018
Dhami-Shah Hiteshi, Vaidya R, Udipi S, Raghavan S, Abhijit S, Mohan V, Balasubramanyam M, Vaidya A. Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis. Clinical and Molecular Hepatology. 2018;24(1):77-87.
2017
Vaidya Ashok, Dhami–Shah Hiteshi. Reverse pharmacology for integrative research in Ayurveda and modern medicine. In Dandiya PC, Kulkarni SK, Khilnani GD (Eds). Pharmacologist of India. 1st ed.New Delhi, India: Vallabh Prakashan; 2017: 81 – 93.
2016
Manglani M, Jadhav S, Dias B. Shah N, Fernandes L, Fernandes S, Surve A, Dhami- Shah Hiteshi, Murty S, Joshi N, A Randomized Controlled Facility Based Trial To Assess The Impact Of Indigenously Prepared Ready To Use Therapeutic Food (RUTF) For Children With Severe Acute Malnutrition In India. Pediatric Oncall Journal. 2016; 13(4): 93 – 98.
2015
Vaidya A, Dhami-Shah Hiteshi. Dr. Ancel Benjamin Keys (1904 – 2004): Monsieur cholesterol and a driven interventionist. Journal of Obesity and Metabolic Research. 2015; 2(3): 179 – 182.
2014
Pathak Namyata, Dhami–Shah Hiteshi, Vadiya Ashok. Clinical Perspective of Ayurceuticals: Challenges and Opportunities for Global Health and Wellness. In. Ghosh Dilip, Bagchi Debasis, Konishi Tetsuya (Eds). Clinical Aspects of Functional Foods and Nutraceuticals. 1st ed.Florida, USA:CRC press; 2014:33 - 50.
Jadhav Alka, Dhami–Shah Hiteshi. Nutritional essentials for children involved in sports. In. Mehta MN, Mehta NJ (Eds). Nutrition and Diet for Children Simplified. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2014: 235 – 240.
Dhami–Shah Hiteshi, Vaidya Rama. Non alcoholic fatty liver disease: A practical guide. Journal of Obesity and Metabolic Research. 2014; 1(1): 62 – 63.
Dhami – Shah Hiteshi. Childhood obesity: A challenge of the 21st century. Journal of Obesity and Metabolic Research. 2014; 1(1): 53 – 54.
Dhami–Shah Hiteshi. Break – The – Fast. Journal of Obesity and Metabolic Research. 2014; 1_259.
2013
Vaidya Rama, Dhami–Shah Hiteshi. Non alcoholic fatty liver diseease: An emerging public health challenge. The Indian Practitioner. 2013;66(4):190 – 191.
